Shares of Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) have been given a consensus broker rating score of 1.25 (Strong Buy) from the four brokers that provide coverage for the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a buy recommendation and three have assigned a strong buy recommendation to the company. […]
